Research ·
Stronger Ozone Dose Tied to Bigger Gains in Knee Arthritis, Turkish Study Finds
In 159 people with knee arthritis, ozone injections at 25 µg/mL were linked to better function and quality of life than 15 µg/mL over three months.
Does the strength of an ozone dose change how much it helps? A team of pain medicine doctors in Turkey looked at that question in people with knee osteoarthritis, the wear-and-tear arthritis of the knee. Their study, published on October 23, 2026 in the journal Medicine, found that patients given the higher of two ozone concentrations went on to report better knee function and a better quality of life over the following three months.
People in both groups improved. The open question was whether a stronger mix added anything, and on most measures it appears it did.
What the researchers did
The work came from the pain medicine divisions of Sakarya University, Marmara University and Sakarya Training and Research Hospital, with Dr. Ridvan Isik as first author. Rather than run a new trial, the team went back through the medical records of patients treated at two university hospital pain clinics between May 2023 and September 2024.
The patients had knee osteoarthritis that ranged from mild to severe on X-ray, with most at the mild end, and the clinics’ records covered adults of about 40 to 81. Each received three injections of an oxygen and ozone gas into the knee joint, one a week, guided by ultrasound so the needle reached the right spot. Every injection was 10 mL of gas. The only difference was its strength: 77 people had received 15 micrograms of ozone per milliliter, and 82 had received 25. All were also given a daily home exercise plan for the knee, hip and thigh muscles.
The doctors compared three scores before treatment and at one and three months: pain on a numeric rating scale, the WOMAC questionnaire (a standard score of knee pain, stiffness and everyday function) and a 12-question survey of physical and mental quality of life.
What they found
Both groups reported clear gains on every measure at one month and at three months. Typical pain scores fell from 8 before treatment to 3 or 4 a month later, then rose back partway by three months.
The higher concentration stood out in several ways:
- Knee function. At three months the typical WOMAC score in the higher-dose group was 39.5, against 57 in the lower-dose group (lower is better).
- Quality of life. At three months, about 82% of the higher-dose group had a meaningful gain in physical quality of life, against 39% on the weaker mix. For mental quality of life the figures were about 81% and 40%.
- Pain. Some 57% of the higher-dose group cut their pain score at least in half, against 40% in the lower-dose group. In the main comparison, though, the gap between the two groups’ pain scores was small and not statistically clear. A second, adjusted analysis did find a larger drop in pain from the start with the stronger mix at three months.
Side effects were minor. One person had brief pain at the injection site and one had brief nausea, and no serious problems were recorded.
What kind of evidence this is
This was a look back at records, not a randomized trial. Doctors chose each patient’s dose as part of normal care, so the two groups may have differed in ways the records do not show. The team used a statistical method to balance the groups on age, body mass index, arthritis grade and starting scores, and the results held. Even so, the authors write that the study cannot prove the stronger dose caused the better results, that follow-up lasted only three months, and that how well patients kept up the home exercises was not objectively tracked. They call their findings exploratory and ask for randomized trials to settle the best dose, number of sessions and timing.
What it means if you are looking at EBO2
This study injected ozone gas straight into the knee. EBO2 (also called EBOO) is a different method: blood flows out of one arm, through a filter where it meets oxygen and ozone, and back into the other arm. The study did not test EBO2, and its numbers do not carry over to it.
What it does add is a useful idea for anyone comparing ozone treatments: the dose may matter, and a careful provider should be able to tell you what concentration they use and why. Our guide on whether EBO2 works sums up the research so far, and side effects and safety covers what to ask before you start. The questions for your doctor tool can help you prepare, and the clinic directory lists providers by state.